Teva Pharmaceutical Industries Ltd. has signed a definitive agreement to acquire 57% of the shares in Taiyo Pharmaceutical Industry Co. Ltd. for $460 million in cash. Teva will also extend an offer to purchase all remaining shares of Taiyo. The total transaction is valued at $1.3 billion. Taiyo is the third largest generic pharmaceutical company in Japan with sales of $530 million in 2010. The company has a generic product portfolio with more than 550 generic drugs in a variety of therapeuti...